Survival and relapse pattern after trimodality therapy for malignant pleural mesothelioma

[1]  M. Okada,et al.  Current Status of Multi-modality Treatment for Malignant Pleural Mesothelioma in Japan , 2008 .

[2]  L. Court,et al.  Restricted field IMRT dramatically enhances IMRT planning for mesothelioma. , 2007, International journal of radiation oncology, biology, physics.

[3]  K. Forster,et al.  Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. , 2007, The Annals of thoracic surgery.

[4]  M. Higashiyama,et al.  [Survey of surgical treatment of malignant pleural mesothelioma in Japan]. , 2007, Kyobu geka. The Japanese journal of thoracic surgery.

[5]  Laurence Court,et al.  Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. , 2006, International journal of radiation oncology, biology, physics.

[6]  R. Stahel,et al.  Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  K. O'Byrne,et al.  The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma. , 2004, The Annals of thoracic surgery.

[8]  Joe Y. Chang,et al.  Promising Early Local Control of Malignant Pleural Mesothelioma Following Postoperative Intensity Modulated Radiotherapy (IMRT) to the Chest , 2003, Cancer journal.

[9]  Claude Denham,et al.  Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  C. N. Coleman,et al.  CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. , 2003, Seminars in radiation oncology.

[11]  K. Forster,et al.  Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma. , 2003, International journal of radiation oncology, biology, physics.

[12]  D. Fielding,et al.  A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma , 2002, British Journal of Cancer.

[13]  A. Jilaihawi,et al.  The management of malignant pleural mesothelioma; single centre experience in 10 years. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[14]  K. Rosenzweig,et al.  A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. , 2001, The Journal of thoracic and cardiovascular surgery.

[15]  E. Ruffini,et al.  Trimodality management of malignant pleural mesothelioma. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[16]  R. Tsuchiya,et al.  Surgical approach to pleural diffuse mesothelioma in Japan. , 2001, Lung cancer.

[17]  A. Musk,et al.  Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  W. Richards,et al.  Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. , 1999, The Journal of thoracic and cardiovascular surgery.

[19]  D. Sugarbaker,et al.  Patterns of failure after trimodality therapy for malignant pleural mesothelioma. , 1997, The Annals of thoracic surgery.

[20]  V. Rusch.  A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group. , 1995, Chest.

[21]  V. Rusch.  Pleurectomy/decortication and adjuvant therapy for malignant mesothelioma. , 1993, Chest.

[22]  R. Ginsberg,et al.  Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  M. Hodson,et al.  Malignant mesothelioma of the pleura: clinical aspects and symptomatic treatment. , 1984, European journal of respiratory diseases.

[24]  R. Weichselbaum,et al.  Radiation therapy in the management of patients with mesothelioma. , 1980, International journal of radiation oncology, biology, physics.